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ABSTRACT In this article, we report the cloning of an aspartic protease (AP) from flowers of Arctium minus (Hill) Bernh.
(Asteraceae) along with the use of depigmented aqueous flower extracts, as a source of APs, for the hydrolysis of whey
proteins. The isolated cDNA encoded a protein product with 509 amino acids called arctiumisin, with the characteristic
primary structure organization of typical plant APs. Bovine whey protein hydrolysates, obtained employing the enzyme
extracts of A. minus flowers, displayed inhibitory angiotensin-converting enzyme (ACE) and antioxidant activities. Hydro-
lysates after 3 and 5 h of reaction (degree of hydrolysis 2.4 and 5.6, respectively) and the associated peptide fraction with
molecular weight below 3 kDa were analyzed by sodium dodecyl sulfate–polyacrylamide gel electrophoresis, matrix-assisted
laser desorption ionization/time of flight mass spectrometry, and reverse phase-high-performance liquid chromatography. The
results obtained in this study demonstrate the viability of using proteases from A. minus to increase the antioxidant and
inhibitory ACE capacity of whey proteins.
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protein  typical plant aspartic protease
INTRODUCTION
Enzymatic hydrolysis, fermentation, or a combi-nation of both have been employed with success
for the production of bioactive peptides. The use of com-
mercial enzymes—for example, pepsin, trypsin, and
chymotrypsin—is still the most common method to produce
bioactive peptides. Less conventional sources of proteolytic
enzymes, which can cleave the whey protein chains at spe-
cific and less usual sites, have been tried.1,2 An interesting
alternative are aspartic proteases (APs) present in the flowers
of Cardueae tribe Cass., Asteraceae family.
Among studied bioactive peptides derived from whey
protein digest, angiotensin-converting enzyme (ACE)-in-
hibitory peptides deserve special mention since ACE is an
effective target for antihypertensive medication in patients
with hypertension—a disorder that constitutes a major
public health problem worldwide.2 Bovine whey protein
concentrates, as well as purified proteins from whey after
hydrolysis by the proteases from cardoon flowers (Cynara
cardunculus), release highly potent ACE-inhibitory pep-
tides.2,3 Active fragments generated from a-lactalbumin and
b-lactoglobulin were different from previously reported
peptides obtained by enzymatic digestion of the same sub-
strate with other peptidases.2,4 The ACE-inhibitory activity
was also reported by Cimino et al.5 upon hydrolysis of whey
protein with flower aqueous extracts of Arctium minus, an-
other member of the Asteraceae family.
The enzymatic hydrolysis of whey protein was also
employed for the generation of bioactive peptides with
antioxidant properties.4,6 The antioxidant activity of pep-
tides comes from their abilities to inactivate reactive
oxygen species, to scavenge free radicals, to chelate pro-
oxidative transition metals, and to reduce hydroperoxides.7
The activity is based on the inherent amino acid compo-
sition and sequence of antioxidant peptides, usually con-
sisting of 5–11 amino acids, including amino acids with
aromatic rings.8
In this work, we isolated the cDNA encoding a novel
typical AP from flowers of A. minus. We employed depig-
mented aqueous enzyme extract (EE) from these flowers to
obtain hydrolysates of whey proteins with antioxidant power
and ACE-inhibitory activity. The herein reported activities
were recovered in both ultrafiltrated whey digests and
fractions separated by reverse phase-high-performance liq-
uid chromatography (RP-HPLC).
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MATERIALS AND METHODS
Plant material
Arctium minus (Hill) Bernh inflorescences were collected
in the surroundings of La Plata (Buenos Aires, Argentina)
during summer (voucher specimen LPE 1164).
Crude extract
Fresh flowers were ground in a mortar under liquid ni-
trogen and homogenized in 0.1M phosphate buffer (pH 7.0)
containing 1mM ethylenediaminetetraacetic acid and 5mM
cysteine. The suspension was stirred for 30min and centri-
fuged at 5000 g for 20min at 4C.5
Enzyme cDNA cloning and sequence analysis
Total RNA was isolated from 100mg of immature flower
of A. minus with the RNeasy Plant mini kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions. Qual-
ity and relative amount of RNA were estimated by agarose gel
electrophoresis. cDNA was synthesized with M-MuLV Re-
verse Transcriptase (Thermo Scientific, Vilnius, Lithuania) and
primer poly-dT17. cDNA was used as template in PCR with
primers specifically designed for highly conserved 50and 30
ends of AP coding sequences (forward primer: 50-ATGGGT
AACTCAATCAAAGCA-30; reverse primer: 50-TCAAGCT
GCTTCTGCAAATCC-30). PCR products were visualized on
a 0.01 g/mL agarose gel and cloned into pGEM-T Easy vector
(Promega, Madison, WI, USA). Plasmid DNA from positive
clones was analyzed by NotI/EcoRI double digestion and
subjected to automated DNA sequencing. Sequences were
analyzed with the Basic Local Alignment Search Tool from the
National Centre for Biotechnology Information and conserved
domains were identified using NCBI’s CD-Search service.9
Peptidase partial purification
An EE was obtained by size exclusion chromatography.5
Protein content was measured following the method of
Bradford,10 using bovine serum albumin (Sigma Chemical
Co., St. Louis, MO, USA) as standard.
Milk clotting activity
Enzyme preparations (100 lL) were added to 1mL skim
milk (0.1 g/mL skim milk powder; San Regim, SanCor,
Sunchales, Santa Fe, Argentina, reconstituted in 30mM
CaCl2, containing 15.4 mM sodium azide) and the clotting
time was measured. Assays were performed at 35C. Posi-
tive and negative controls were carried out with an extract of
flowers of Cynara scolymus11 and extracting buffer, re-
spectively. One rennet unit is the amount of enzyme that
coagulates 10mL milk in 100 s in the assay conditions.12
Enzymatic hydrolysis of bovine whey
Substrate for hydrolysis consisted of a 0.01 g/mL whey
suspension (LAC PRODAN 80; Arla Foods Ingredients
S.A., Martinez, Buenos Aires, Argentina) with a protein
concentration of 3.8– 0.2mg/mL estimated by the micro-
Kjeldahl technique.13 Reaction was started by addition of
4.6mL of substrate to 90 lL of the EE. The reactions were
performed at 35C and quenched at 3 and 5 h by 5min of
boiling. Controls containing whey suspension at the same
concentration without enzyme addition were performed.
Samples were analyzed by 0.2 g/mL discontinuous sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-
PAGE).14 Gels were stained with Coomassie Blue G-250.
Fractionation, enrichment, and mass spectrometry
profile of bioactive peptides
Hydrolyzed whey was ultrafiltrated in Amicon Ultra-15
centrifugal filter units with Ultracel-3 membrane (Merck
Millipore, Billerica, MA, USA) in a swinging bucket rotor at
4000 g. Lowmolecular fractions ( £ 3000 Da) were analyzed
by matrix-assisted laser desorption ionization/time of flight
mass spectrometry (MALDI/TOFMS), and the spectra were
acquired on a Bruker ultrafleXtrem spectrometer equipped
with a Smartbeam-II laser in reflectron-positive mode using
a matrix of a-cyano-4-hydroxycinnamic acid.
Degree of hydrolysis determination
The sample (0.04mL) was mixed in a test tube with 0.32mL
of 0.2125M phosphate buffer (pH 8.2) containing 0.01 g/mL
SDS and 0.32mL of 1% v/v 2, 4, 6-trinitrobenzenesulfonic acid
in water.15 Mixtures were incubated at 50C for 60min pro-
tected from light. Reactions, quenched by addition of 0.64mL
of 0.1N HCl, were incubated at room temperature for 60min.
Absorbance was measured at 340nm. Controls were performed
with water.
The concentration of free amino group liberated was
expressed as leucine equivalent using a calibration curve
constructed with standard leucine (0.225–2.25mM). Degree
of hydrolysis (DH) percentage was calculated employing the
following equation:
DH%¼ 100· (NH2 tNH2 t¼ 0)=(NH21 NH2 t¼ 0)
NH2 t = 0 and NH2 t indicate the concentration of free
amino groups in the nonhydrolyzed sample and at different
hydrolysis time, respectively. Whereas-NH2 N, represent-
ing total hydrolysis, was estimated according to
NH2 1¼ (1=Maa) · (1þ fLys) ·Cprot · 1000
Maa is the average molecular weight of amino acids
present in whey proteins (130 g/mol), fLys is the proportion
of lysine in whey proteins (1/15), and Cprot is the protein
concentration (g/L).
HPLC analysis
The 3 kDa permeates of digested whey proteins were an-
alyzed by RP-HPLC (A¨KTA Purifier; GE Healthcare, Up-
psala, Sweden) using a LiChrospher 100 RP-C18 (5 lm,
250· 4mm; Merck, Darmstadt, Germany). Chromatographic
conditions included solvent A, 0.1% v/v trifluoroacetic acid
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in H20; solvent B, 0.1% v/v trifluoroacetic acid in CH3CN/
H20 50:50; flow rate, 0.8mL/min; detection at 215 and
280nm. A fraction below 3 kDa of control bovine whey was
also analyzed under the same conditions.
Scavenging of ABTS+  radical
ABTS+  cation radical [2,20-azino-bis-(3-ethylben-
zothiazoline-6-sulfonic acid)] scavenging ability was mea-
sured, as described by Kumaraswamy and Satish,16 with
slight modifications. ABTS +  was produced by reaction of
7mMABTS and 2.45mM potassium persulfate incubated at
room temperature for 16 h in darkness. The ABTS+  solu-
tion was diluted with 5.0mM phosphate buffer (pH 7.4) to a
final absorbance of 0.70– 0.02 at 734 nm. ABTS+ $dilution
aliquots of 1mL were mixed with 10 lL of hydrolysate
samples or different concentrations of Trolox (6-hydroxy-
2,5,7,8-tetramethychroman-2-carboxylic acid) as antioxidant
standard. Ten minutes later, the absorbance was measured at
734 nm against the corresponding blank. The percentage of
inhibition was calculated from
% inhibition¼ [(AB0 minAS10 min) (AB0 minAB10 min)]
· 100=AB0 min
AB0min and AB10min are the absorbance of reaction mix-
tures without sample at 0 and 10min, respectively, whereas
AS10min is the absorbance of the mixtures with sample at
10min.
Results were expressed in percentages of scavenging
capacity (mean of triplicate determinations – standard de-
viations) and in mg of Trolox equivalents per mL of sample.
b-carotene-linoleic acid assay
The antioxidant activity was determined employing the
method of Tepe et al.17 with modifications. First, 0.8mg b-
carotene was dissolved in 4mL chloroform (HPLC grade),
then 80mg linoleic acid and 800mg Tween 20 were added.
Chloroformwas completely evaporated at 40C. Subsequently,
200mL of distilled water saturated with oxygen was added
with vigorous shaking; 2.5mL of this reactive was dispensed to
test tubes with the addition of 0.1mL of samples, water (neg-
ative control), or ascorbic acid standard solution (positive
control, concentration range: 0.1–0.00001g/mL). The emul-
sion system was incubated for 120min at 50C. Absorbance
was measured at 470nm at 0, 30, 60, 90, and 120min. The
antioxidant activity percentage was determined as follows:
absorbance (final time)/absorbance (initial time)·100.
Inhibitory ACE activity
RP-HPLC selected peaks were tested for ACE in vitro
inhibition. Kinetic assays were performed using fluorescence
resonance energy transfer substrate Abz-PheArgLys(DNP)-
Pro-OH18 in a spectrofluorometer RF-1501 (Shimadzu Cor-
poration, Kyoto, Japan), recording fluorescence emission
(kex 320 nm; kem 420nm) during 3min. Controls were per-
formed employing captopril stock (217.29 lg/mL in water),
EE, a 3 kDa whey permeate previously exposed to the same
temperature treatment, and buffer.
Determinations were performed in triplicate and standard
deviations were calculated. Data were expressed as inhibi-
tion percentage.
RESULTS AND DISCUSSION
cDNA cloning and sequence analysis
APs are present in a wide variety of plant species and
have been characterized and purified from different tis-
sues.19 Because of their diversity, plant APs have been
grouped into three classes—that is typical plant-aspartic,
atypical plant-aspartic, and nucellin-like proteinases—
depending on their putative domain organizations and their
active-site-sequence motifs.20 cDNA was synthesized using
total RNA isolated from A. minus young flowers and used as
PCR template with primers designed for conserved regions
of the open reading frame 50 and 30 ends of plant APs. The
amplified product of 1530 bp was cloned. The nucleotide
and deduced amino acid sequences are shown in Figure 1
(GenBank accession number: KJ452158). According to the
AP-naming conventions, we proposed the name arctiumsin
for the aspartyl endopeptidase cloned in this research. This
protein product encoded a preproenzyme of 509 residues
with a putative hydrophobic signal peptide of 24 amino
acids, a prosegment of 44 residues, and a 441 amino acid-
long polypeptide interrupted by 105 residues corresponding
to the plant-specific insert (PSI) domain. Neither PSI se-
quences nor PSI structures have homology with animal or
microbial APs; however, the PSI domain is homologous
with the precursor of mammalian saposins.21 The pre-
proenzyme has a predicted molecular mass of 55 kDa with a
theoretical pI of 5.3. Protein sequence and conserved do-
main analysis9 confirmed the nature of cDNA-deduced
amino acid sequence as AP homologue.
When compared with other plant AP precursors (Fig. 2), the
amino acid sequence of arctiumsin showed a high degree of
similarity with cirsin (AFB73927) from Cirsium vulgare
(identities: 96%, positives: 98%), cyprosin B (CAA57510)
from C. cardunculus (identities: 96%, positives: 98%), cen-
prosin (CAA70340) from Centaurea calcitrapa (identities:
96%, positives: 98%), silpepsin 1 from Silybum marianum
(AGE15494, identities: 95%, positives: 98%), the AP from
Helianthus annuus (BAA76870, identities: 82%, positives:
91%), all peptidases belonging to A1 family, MEROPS-the
Peptidase Database (http://merops.sanger.ac.uk/).
APs from family A1 are bilobed molecules with two as-
partic residues responsible for catalysis located on each side
of a catalytic cleft. The deduced amino acid sequence
presents two conserved catalytic triads, DTG 103–105 and
DTG 290–292 corresponding to DTG 32–34 and DTG 215–
217 of pepsin numbering, respectively. Additional con-
served residues—found to participate in substrate align-
ment, specificity, and/or efficient catalysis22—are tyrosine,
glycine, and threonine residues in positions 147, 148, and
149 (YGT 75–77 using pepsin numbering). Furthermore,
two putative N-glycosylation sites conserved in several
BIOACTIVE PEPTIDES PRODUCED BY ARCTIUMSIN 3
FIG. 1. Full-length cDNA and derived amino
acid sequence of artiumsin. First strand cDNA
was synthesized from total RNA isolated from
young flower buds and used as a template in PCR
amplification with primers specifically designed
for the highly conserved 50 and 30 ends of aspartic
proteases (APs) coding sequences. The regions
corresponding to the N-terminal signal peptide
(dotted arrow), the prosegment (dashed arrow),
and the plant-specific insert (italic) are indicated.
Potential N-linked glycosylation sites are circled
and the catalytic triads are boxed. Artiumsin cDNA
sequence has been submitted to the GenBank under
the accession number KJ452158.
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FIG. 2. Amino acid sequence alignment of thistle APs. The regions corresponding to the N-terminal signal peptide and the prosegment are
indicated by boxed light gray and dark gray, respectively. Potential N-glycosylation sites are grayed out and the catalytic triads are boxed.
Sequence of the enzymes used for the alignment are preprocirsin (Cirsium vulgare) AFB73927.2, cyprosin (Cynara cardunculus) CAA57510.1,
cenprosin CAA70340.1 (Centaurea calcitrapa), and preprosilpepsin AGE15494.11 (Silybum marianum).
5
typical plant APs23 were also predicted at residues N139 and
N400 (Asn-X-Ser/Thr motives).
Production of bioactive peptides
Aqueous crude extracts from flowers of genus Cynara are
traditionally employed in the Iberian Peninsula as vegetable
rennet for cheesemaking.24 APs are responsible for the milk
clotting activity (MCA) of these flower extracts; MCA was
also proven in flower extracts on other members of the
Cardueae tribe—for example, A. minus. In this article, a
crude extract with 0.0167 RU/mL of MCA was partially
purified by size exclusion chromatography. The resulting
EE with 208– 4 lg protein/mL retained 0.001449 RU/mL.
Bioactive peptides are considered as prominent candi-
dates for various health-promoting and disease risk reduc-
tion functional foods. The most common way to produce
bioactive peptides is through enzymatic hydrolysis of whole
protein molecules.25 Whey protein is an abundant low-cost
by-product of the dairy industry that has high nutritional,
functional, and biological value.6 Whey proteins were sus-
ceptible to proteolysis by EE from A. minus flowers. The
extract employed is a source of APs, which are able to
cleave whey proteins at more specific and unusual sites than
those that commercial enzymes can do.5 The degradation
profile of whey hydrolysates were analyzed by SDS-PAGE
(data not shown). Although bands corresponding to poly-
peptides produced by the hydrolysis were not observed by
FIG. 3. Matrix-assisted laser de-
sorption ionization/time-of-flight mass
spectrometry spectra of (A) low mo-
lecular fractions ( £ 3 kDa) of whey
protein control and of (B) whey pro-
teins hydrolyzed for 3 h with enzyme
extracts of Arctium minus flowers.
Table 1. Analysis of Masses from Mass Spectrum with FindPept Tool
Bovine whey protein sequence analyzed Matched peptides D mass (Da) Position in protein
a-Lactalbumin Not found
b-Lactoglobulin (L)EILLQKWENGECAQ(K) - 0.004 71–84
(T)DYKKYLLFCMENSA(E) 0.006 114–127
Serum albumin (R)RPCFSALTPDETY(V) 0.009 508–520
(L)VDEPQNLIKQNCDQ(F) - 0.008 404–417
(K)DVCKNYQEAKDAFL(G) - 0.004 337–350
(C)CAADDKEACFAVEGPKL(V) 0.001 582–598
Lactoferrin (N)DTVWENTNGE(S) - 0.006 565–574
(N)IPMGLIVNQTGSCA(F) - 0.008 488–501
(L)AENRKSSKHSSLDCV(L) 0.002 431–445
http://www.expasy.org/tools/findpept.html.
Mass peaks ranging from 1000 to 2500 Da (m/z) present in the hydrolyzed sample mass spectrum and absent in the control were subjected to analysis with
FindPept tool to identify possible peptides derived from whey proteins, which could be assigned to the peaks of the spectrum.
Analysis conditions were mass tolerance of 0.01 Da, cysteines treated with iodoacetamide (underlined), and unspecific cleavage. Amino acids in brackets are
residues forming the putative scissile bonds.
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SDS-PAGE, main whey protein bands became less intense
as reaction time elapsed. The hydrolysates after 3 or 5 h
of reaction were characterized by DH of 2.4– 0.4% and
5.6– 0.5%, respectively.
Peptide mixtures with antioxidant and ACE inhibitory
activities under optimal processing conditions (tempera-
ture, pH, and time) were obtained; that is, bioactive pep-
tides encrypted in intact molecules were released from
their encrypted position by A. minus APs during the reac-
tion. Many studies have described protein hydrolysates
from various sources that exhibit remarkable antioxidant
properties. Tavares et al.2 reported that peptides produced
by digestion of whey protein concentrates and a-lactalbu-
min with APs from cardoon flowers exhibited a scarce
antioxidant activity. On the contrary, Contreras et al.6 have
demonstrated a high antioxidant activity in thermolysin
whey protein concentrate hydrolysates. The total in vitro
antioxidant activity of raw whey hydrolysates after 3 and
5 h of reaction was calculated from the decolorization of
ABTS + . Hydrolysates of 3 h displayed 11.6 – 6.5% of
antioxidant activity with a Trolox equivalent antioxidant
concentration of 0.06 – 0.03mg/mL, while hydrolysates of
5 h showed 19.5 – 1.8% of antioxidant activity, which
corresponds to 0.10 – 0.01mg/mL of Trolox. In view of
these results, the 5-h hydrolysate was selected for subse-
quent antioxidant activity determinations.
To obtain a more uniform product and taking into ac-
count that bioactive peptides usually contain 3–20 amino
FIG. 4. (A) Typical chromatogram pertaining to fractionation by RP-HPLC of the £3kDa-permeate obtained from bovine whey proteins (control
chromatographic profile), (B) typical chromatogrampertaining to fractionation byRP-HPLCof the £3kDa-permeate obtained frombovinewhey proteins by
enzyme extracts of Arctiumminus after 5h of hydrolysis, and (C) after 3h of hydrolysis. RP-HPLC, reverse phase-high-performance liquid chromatography.
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acids,26 the crude protein hydrolysate was processed by
passage through ultrafiltration 3 kDa molecular weight cut-
off membrane. Resulting permeate was analyzed by MAL-
DI/TOF MS (Fig. 3). Several mass peaks ranging from 1000
to 2500 Da (m/z)—absent in the control—were observed in
the hydrolyzed sample spectra. As the specificity of the
proteolytic cleavage of the protease/s of EE is not yet
known, FindPept27 (http://expasy.org/tools/findpept.html)
was used to identify possible peptides derived from whey
proteins, which could be assigned to the peaks of the spec-
trum with a mass tolerance of 0.01 Da (Table 1).
Antioxidant activity of the ultrafiltration permeate of the
5-h hydrolysate was evaluated by b-carotene linoleic acid
assay. Bleaching inhibition of b-carotene was 12.6– 1.4%.
Permeated fraction of the 5-h degradation time was frac-
tionated by RP-HPLC (Fig. 4B). When comparing with the
control chromatographic profile (Fig. 4A), nine peaks with
low retention times were observed (Fig. 4B). The antioxi-
dant capacity of RP-HPLC fractions of 5-h hydrolysates was
analyzed by the method of b-carotene linoleic acid. As
shown in Table 2, peaks with 3.44, 4.1, 4.54, and 5.53 re-
tention time retained the antioxidant activity with values in
the range of 0.16–0.94 g/mL of ascorbic acid.
ACE inhibitors interfere with the renin–angiotensin sys-
tem and the kinin–kallikrein system, twometabolic pathways
associated with the control of blood pressure. The ability to
inhibit ACE in vitro is indicative of the potential of a given
protein-derived peptide to act as a hypotensive agent in vivo.28
Hydrolysates of whey proteins and fractions enriched in in-
dividual milk proteins are potentially good sources of ACE
inhibitory peptides. Classical approaches involve the in vitro
determination of the ACE inhibitory activity of milk protein
hydrolysates, obtained by enzymatic digestion or microbial
fermentation.29 Cimino et al.5 reported that a 3 kDa permeate
of digested whey proteins hydrolyzed for 3 h with EE of A.
minus flowers showed 22.0– 3.4% ofACE inhibitory activity,
the obtained value for Captopril standard (5.43 ng/mL) was
29.6– 2.6%, while 16.8– 0.5% of ACE inhibition was de-
tected for control whey. Authors also noted that the fraction
below 3 kDa of a 5-h hydrolysate presented a considerably
lower activity. According to these results, permeated fraction
of 3 h was fractionated by RP-HPLC. When comparing with
the control chromatographic profile (Fig. 4A), 12 peaks with
low retention times were observed (Fig. 4C). Major peaks
obtained through RP-HPLC were selected for ACE inhibitory
activity analysis. 10.1– 3.6%, 22.4– 3.2%, and 4.1– 2.6% of
ACE inhibition were recovered for the peaks with 26.5, 27.26,
and 34.27min of retention time, respectively. ACE inhibitory
peptides are not as potent as the drugs commonly used for
hypertension treatment, but if protein hydrolysates exhibiting
this activity are included in the formulation of functional
foods, they can easily be included in the daily diet.
Conclusions
cDNA encoding a typical aspartic proteinase precursor,
preproarctiumsin, was isolated from A. minus immature
flowers. Arctiumsin shows significant similarity in the amino
acid sequence to other peptidases that belong to family A1
(MEROPS Database). Results obtained in this study dem-
onstrate the viability of using the proteases from A. minus
flowers to increase the antioxidant and ACE inhibitory ca-
pacity of whey proteins. After 3 h of digestion (DH= 2.4–
0.4%), the whey protein hydrolysate displayed a higher ACE
inhibitory activity than the 5-h hydrolysate (DH= 5.6–
0.5%). By contrast, the 5-h protein digest exhibited a higher
antioxidant activity than the lesser degraded protein mixture.
Both the crude protein hydrolysates were processed by
passage through ultrafiltration 3 kDamolecular weight cutoff
membrane and the bioactivities were recovered in the per-
meate fractions. Ultrafiltration was followed by RP-HPLC
and several peaks maintained their corresponding activities.
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